Report Detail

Request for Sample of this report

Chemical & Material Global Cyclophosphamide Monohydrate Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4514016
    • |
  • 19 February, 2023
    • |
  • Global
    • |
  • 101 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Chemical & Material

Cyclophosphamide Monohydrate is niche oncology API used for the treatment of malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin's disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, Burkitt's lymphoma. multiple myeloma.. Available for all global markets except the US along with DMF support. Available as both sterile grade (for injectables) and non-sterile grade (for tablets)
According to our (Global Info Research) latest study, the global Cyclophosphamide Monohydrate market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cyclophosphamide Monohydrate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cyclophosphamide Monohydrate market size and forecasts, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Cyclophosphamide Monohydrate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Cyclophosphamide Monohydrate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Cyclophosphamide Monohydrate market shares of main players, shipments in revenue ($ Million), sales quantity (Kiloton), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cyclophosphamide Monohydrate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cyclophosphamide Monohydrate market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter Healthcare, Evonik Industries, Jiangsu Hengrui Medicine, Fermion Oy and Orion Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Cyclophosphamide Monohydrate market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sterile Grade
Non-sterile Grade
Market segment by Application
Injection
Tablets
Major players covered
Baxter Healthcare
Evonik Industries
Jiangsu Hengrui Medicine
Fermion Oy
Orion Corporation
American Pacific Corporation
Apothecon Pharmaceuticals
Hetero Drugs Limited
Aarti Industries
Nishchem International
Olainfarm JSC
Jiwan Pharmaceutical Technology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cyclophosphamide Monohydrate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cyclophosphamide Monohydrate, with price, sales, revenue and global market share of Cyclophosphamide Monohydrate from 2018 to 2023.
Chapter 3, the Cyclophosphamide Monohydrate competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cyclophosphamide Monohydrate breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cyclophosphamide Monohydrate market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cyclophosphamide Monohydrate.
Chapter 14 and 15, to describe Cyclophosphamide Monohydrate sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cyclophosphamide Monohydrate
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cyclophosphamide Monohydrate Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Sterile Grade
    • 1.3.3 Non-sterile Grade
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cyclophosphamide Monohydrate Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Injection
    • 1.4.3 Tablets
  • 1.5 Global Cyclophosphamide Monohydrate Market Size & Forecast
    • 1.5.1 Global Cyclophosphamide Monohydrate Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Cyclophosphamide Monohydrate Sales Quantity (2018-2029)
    • 1.5.3 Global Cyclophosphamide Monohydrate Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Baxter Healthcare
    • 2.1.1 Baxter Healthcare Details
    • 2.1.2 Baxter Healthcare Major Business
    • 2.1.3 Baxter Healthcare Cyclophosphamide Monohydrate Product and Services
    • 2.1.4 Baxter Healthcare Cyclophosphamide Monohydrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Baxter Healthcare Recent Developments/Updates
  • 2.2 Evonik Industries
    • 2.2.1 Evonik Industries Details
    • 2.2.2 Evonik Industries Major Business
    • 2.2.3 Evonik Industries Cyclophosphamide Monohydrate Product and Services
    • 2.2.4 Evonik Industries Cyclophosphamide Monohydrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Evonik Industries Recent Developments/Updates
  • 2.3 Jiangsu Hengrui Medicine
    • 2.3.1 Jiangsu Hengrui Medicine Details
    • 2.3.2 Jiangsu Hengrui Medicine Major Business
    • 2.3.3 Jiangsu Hengrui Medicine Cyclophosphamide Monohydrate Product and Services
    • 2.3.4 Jiangsu Hengrui Medicine Cyclophosphamide Monohydrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Jiangsu Hengrui Medicine Recent Developments/Updates
  • 2.4 Fermion Oy
    • 2.4.1 Fermion Oy Details
    • 2.4.2 Fermion Oy Major Business
    • 2.4.3 Fermion Oy Cyclophosphamide Monohydrate Product and Services
    • 2.4.4 Fermion Oy Cyclophosphamide Monohydrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Fermion Oy Recent Developments/Updates
  • 2.5 Orion Corporation
    • 2.5.1 Orion Corporation Details
    • 2.5.2 Orion Corporation Major Business
    • 2.5.3 Orion Corporation Cyclophosphamide Monohydrate Product and Services
    • 2.5.4 Orion Corporation Cyclophosphamide Monohydrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Orion Corporation Recent Developments/Updates
  • 2.6 American Pacific Corporation
    • 2.6.1 American Pacific Corporation Details
    • 2.6.2 American Pacific Corporation Major Business
    • 2.6.3 American Pacific Corporation Cyclophosphamide Monohydrate Product and Services
    • 2.6.4 American Pacific Corporation Cyclophosphamide Monohydrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 American Pacific Corporation Recent Developments/Updates
  • 2.7 Apothecon Pharmaceuticals
    • 2.7.1 Apothecon Pharmaceuticals Details
    • 2.7.2 Apothecon Pharmaceuticals Major Business
    • 2.7.3 Apothecon Pharmaceuticals Cyclophosphamide Monohydrate Product and Services
    • 2.7.4 Apothecon Pharmaceuticals Cyclophosphamide Monohydrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Apothecon Pharmaceuticals Recent Developments/Updates
  • 2.8 Hetero Drugs Limited
    • 2.8.1 Hetero Drugs Limited Details
    • 2.8.2 Hetero Drugs Limited Major Business
    • 2.8.3 Hetero Drugs Limited Cyclophosphamide Monohydrate Product and Services
    • 2.8.4 Hetero Drugs Limited Cyclophosphamide Monohydrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Hetero Drugs Limited Recent Developments/Updates
  • 2.9 Aarti Industries
    • 2.9.1 Aarti Industries Details
    • 2.9.2 Aarti Industries Major Business
    • 2.9.3 Aarti Industries Cyclophosphamide Monohydrate Product and Services
    • 2.9.4 Aarti Industries Cyclophosphamide Monohydrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Aarti Industries Recent Developments/Updates
  • 2.10 Nishchem International
    • 2.10.1 Nishchem International Details
    • 2.10.2 Nishchem International Major Business
    • 2.10.3 Nishchem International Cyclophosphamide Monohydrate Product and Services
    • 2.10.4 Nishchem International Cyclophosphamide Monohydrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Nishchem International Recent Developments/Updates
  • 2.11 Olainfarm JSC
    • 2.11.1 Olainfarm JSC Details
    • 2.11.2 Olainfarm JSC Major Business
    • 2.11.3 Olainfarm JSC Cyclophosphamide Monohydrate Product and Services
    • 2.11.4 Olainfarm JSC Cyclophosphamide Monohydrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Olainfarm JSC Recent Developments/Updates
  • 2.12 Jiwan Pharmaceutical Technology
    • 2.12.1 Jiwan Pharmaceutical Technology Details
    • 2.12.2 Jiwan Pharmaceutical Technology Major Business
    • 2.12.3 Jiwan Pharmaceutical Technology Cyclophosphamide Monohydrate Product and Services
    • 2.12.4 Jiwan Pharmaceutical Technology Cyclophosphamide Monohydrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Jiwan Pharmaceutical Technology Recent Developments/Updates

3 Competitive Environment: Cyclophosphamide Monohydrate by Manufacturer

  • 3.1 Global Cyclophosphamide Monohydrate Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Cyclophosphamide Monohydrate Revenue by Manufacturer (2018-2023)
  • 3.3 Global Cyclophosphamide Monohydrate Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Cyclophosphamide Monohydrate by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Cyclophosphamide Monohydrate Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Cyclophosphamide Monohydrate Manufacturer Market Share in 2022
  • 3.5 Cyclophosphamide Monohydrate Market: Overall Company Footprint Analysis
    • 3.5.1 Cyclophosphamide Monohydrate Market: Region Footprint
    • 3.5.2 Cyclophosphamide Monohydrate Market: Company Product Type Footprint
    • 3.5.3 Cyclophosphamide Monohydrate Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cyclophosphamide Monohydrate Market Size by Region
    • 4.1.1 Global Cyclophosphamide Monohydrate Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Cyclophosphamide Monohydrate Consumption Value by Region (2018-2029)
    • 4.1.3 Global Cyclophosphamide Monohydrate Average Price by Region (2018-2029)
  • 4.2 North America Cyclophosphamide Monohydrate Consumption Value (2018-2029)
  • 4.3 Europe Cyclophosphamide Monohydrate Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Cyclophosphamide Monohydrate Consumption Value (2018-2029)
  • 4.5 South America Cyclophosphamide Monohydrate Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Cyclophosphamide Monohydrate Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Cyclophosphamide Monohydrate Sales Quantity by Type (2018-2029)
  • 5.2 Global Cyclophosphamide Monohydrate Consumption Value by Type (2018-2029)
  • 5.3 Global Cyclophosphamide Monohydrate Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Cyclophosphamide Monohydrate Sales Quantity by Application (2018-2029)
  • 6.2 Global Cyclophosphamide Monohydrate Consumption Value by Application (2018-2029)
  • 6.3 Global Cyclophosphamide Monohydrate Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Cyclophosphamide Monohydrate Sales Quantity by Type (2018-2029)
  • 7.2 North America Cyclophosphamide Monohydrate Sales Quantity by Application (2018-2029)
  • 7.3 North America Cyclophosphamide Monohydrate Market Size by Country
    • 7.3.1 North America Cyclophosphamide Monohydrate Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Cyclophosphamide Monohydrate Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Cyclophosphamide Monohydrate Sales Quantity by Type (2018-2029)
  • 8.2 Europe Cyclophosphamide Monohydrate Sales Quantity by Application (2018-2029)
  • 8.3 Europe Cyclophosphamide Monohydrate Market Size by Country
    • 8.3.1 Europe Cyclophosphamide Monohydrate Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Cyclophosphamide Monohydrate Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cyclophosphamide Monohydrate Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Cyclophosphamide Monohydrate Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Cyclophosphamide Monohydrate Market Size by Region
    • 9.3.1 Asia-Pacific Cyclophosphamide Monohydrate Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Cyclophosphamide Monohydrate Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Cyclophosphamide Monohydrate Sales Quantity by Type (2018-2029)
  • 10.2 South America Cyclophosphamide Monohydrate Sales Quantity by Application (2018-2029)
  • 10.3 South America Cyclophosphamide Monohydrate Market Size by Country
    • 10.3.1 South America Cyclophosphamide Monohydrate Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Cyclophosphamide Monohydrate Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cyclophosphamide Monohydrate Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Cyclophosphamide Monohydrate Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Cyclophosphamide Monohydrate Market Size by Country
    • 11.3.1 Middle East & Africa Cyclophosphamide Monohydrate Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Cyclophosphamide Monohydrate Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Cyclophosphamide Monohydrate Market Drivers
  • 12.2 Cyclophosphamide Monohydrate Market Restraints
  • 12.3 Cyclophosphamide Monohydrate Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cyclophosphamide Monohydrate and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cyclophosphamide Monohydrate
  • 13.3 Cyclophosphamide Monohydrate Production Process
  • 13.4 Cyclophosphamide Monohydrate Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cyclophosphamide Monohydrate Typical Distributors
  • 14.3 Cyclophosphamide Monohydrate Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cyclophosphamide Monohydrate. Industry analysis & Market Report on Cyclophosphamide Monohydrate is a syndicated market report, published as Global Cyclophosphamide Monohydrate Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Cyclophosphamide Monohydrate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo